Development of Biomarkers for Monitoring Menopause in Women
Recruiting
Observational Study
Perimenopausal Biomarkers
Mitochondrial Biomarkers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Fu Jen Catholic University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative and quantita…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Biological female, age order than 20 years old.
Exclusion Criteria:
* Person with cancer.
* Person with any known acute or chronic infection.
* Person with known chronic illness under follow up or treatment.
* Pregnancy, one year withing delivery, under breast feeding, or th…
Contacts